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Sustainable biofuel alternatives to fossil fuel energy are hampered by recalcitrance and toxicity of
biomass substrates to microbial biocatalysts. To address this issue, we present a culture-
independent functional metagenomic platform for mining Nature’s vast enzymatic reservoir and
show its relevance to biomass conversion. We performed functional selections on 4.7 Gb of
metagenomic fosmid libraries and show that genetic elements conferring tolerance toward seven
important biomass inhibitors can be identified. We select two metagenomic fosmids that improve
the growth of Escherichia coli by 5.7- and 6.9-fold in the presence of inhibitory concentrations of
syringaldehyde and 2-furoic acid, respectively, and identify the individual genes responsible for
these tolerance phenotypes. Finally, we combine the individual genes to create a three-gene
construct that confers tolerance to mixtures of these important biomass inhibitors. This platform
presents a route for expanding the repertoire of genetic elements available to synthetic biology and
provides a starting point for efforts to engineer robust strains for biofuel generation.
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Introduction
Global environmental problems related to the combustion of
fossil fuels and increasing concerns about their supply
underscore the importance of developing renewable fuel
alternatives with a reduced environmental footprint. The
application of synthetic biology (Baker et al, 2006; Ro et al,
2006) to engineer biocatalysts that produce biofuels from
diverse lignocellulosic materials including waste and low
agricultural intensity biomass holds promise to deliver one
such sustainable alternative (Farrell et al, 2006; Tilman et al,
2006; Fargione et al, 2008; Searchinger et al, 2008). However,
bioconversion of lignocellulose to biofuels is currently limited
by biomass recalcitrance (Himmel et al, 2007) and toxicity of
non-fermentable compounds in the original substrate and
formed as byproducts of biomass pretreatment (Klinke et al,
2004). Although the identity and inhibitory concentrations of
these compounds have been characterized, their mechanisms
of toxicity are poorly understood, and genes conferring
tolerance to most of these compounds have not been
identified. A synthetic biology approach to design efficient
biocatalysts for biofuel generation requires a diverse inventory
of functional genetic machinery allowing usage of or
conferring tolerance toward these compounds.
As plant biomass is constantly recycled in the environment
(Kirk and Farrell, 1987), a reservoir of enzymatic machinery
must exist in the soil microbiome that allows for the tolerance
and complete processing of its constituent chemicals. How-
ever, the majority of this microbial processing machinery has
remained inaccessible to synthetic biology and metabolic
engineering, as a majority of microbes in the soil are
recalcitrant to culturing (Torsvik et al, 1998). We show the
utility of culture-independent metagenomic functional selec-
tions for discovery of novel functional genes from the soil
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microbiome, enabling expansion of the synthetic biology
toolbox for lignocellulosic biomass conversion and tolerance.
The key steps of this method involve extraction of metage-
nomic DNA from arbitrary environmental sources (Rondon
et al, 2000), transformation of environmental metagenomic
libraries into the microbial host of interest, and selection of
functional genetic elements conferring the desired phenotype
compatible with the chosen host (Figure 1). This method is
well suited for biomass catalysis, as the functional genes that
allow the host to use recalcitrant substrates or tolerate toxic
chemicals can be directly selected from arbitrarymetagenomic
libraries.
Results and discussion
Engineered Escherichia coli strains have been shown to harbor
many advantages as biocatalysts for biofuel production,
including the ability to ferment a majority of plant-derived
monosaccharides, no requirements for complex growth
factors, and earlier industrial use, but still suffer from lower
tolerance to biomass inhibitors when compared with other
candidate biofuel producing organisms (Dien et al, 2003).
Therefore, as a proof of concept, we applied metagenomic
functional selections to select a number of functional genetic
elements from diverse soil microbiomes that confer resistance
in E. coli to different classes of biomass inhibitors. We
extracted metagenomic DNA from four different soil micro-
biomes (Table I), with an optimized protocol to carefully purify
high molecular weight DNA (Materials and methods; Supple-
mentary methods). We chose to create large-insert (40–50kb)
libraries to allow for the potential discovery of phenotypes
requiring multiple genes. Four metagenomic libraries of sizes
ranging from 0.2 to 2.5Gbwere created in a single-copy fosmid
vector, and transferred into an E. coli host using phage
transduction (Table I; Materials and methods). The concentra-
tions of seven important biomass chemicals that inhibit the
growth of the wild-type E. coli host were determined using
growth assays on Luria Broth (LB) agar media with sparse
concentration range screening (Supplementary Table I) based
on previously published results (Zaldivar and Ingram, 1999;
Zaldivar et al, 1999, 2000). These chemicals span the three
major classes of biomass inhibitors (organic acids, alcohols,
and aldehydes), which accumulate during the pretreatment of
biomass and agricultural and municipal waste, resulting in the
inhibition of microbial biofuel fermentation (Klinke et al,
2004). Selection of the four metagenomic libraries on solid
media containing each of the seven biomass compounds at
their determined inhibitory concentrations yielded metage-
nomic library clones that survived in 15 of the 28 combinations
(Table I). Tolerant clones were identified against all seven
inhibitors. Methylcatechol was the only compound for which
tolerant clones were identified from all four soil libraries.
Hydroquinone and furfural tolerant clones were identified in
one library. Interestingly, the medium-sized (1Gb) dairy farm
soil library yielded clones tolerant to the most inhibitors (six
out of seven), whereas the pH 5.5 bog soil library with the
largest size (2.5Gb) yielded clones tolerant to two of the
seven inhibitors. These phenotypic results show the utility
of metagenomic functional selections for transferring ligno-
cellulosic inhibitor tolerance phenotypes to E. coli. As these
phenotypes are encoded on large DNA inserts, it is important
to identify which and how many specific genetic elements
within these operon-sized stretches are responsible for these
phenotypes. As a proof of concept, we chose to focus on a
subset of clones for more in-depth analysis of growth kinetics
in the presence of inhibitors, sequencing of the full-length
inserts, and sub-cloning of functionally annotated genes.
Inhibitory chemicals are derived from two major sources
during biomass pretreatment—depolymerization of complex
lignin polymers and degradation of biomass sugars (Klinke
et al, 2004). Accordingly, we chose clones conferring tolerance
to one lignin monomer, syringaldehyde, and one biomass
sugar degradation product, 2-furoic acid, for further pheno-
typic and genetic analysis. For each inhibitor, 20 metagenomic
clones with improved tolerance on solid selection media
(Supplementary Table I) were retested in liquid culture at three
concentrations spanning the range of previously reported
inhibitory concentrations (Materials and methods), and for all
clones improved phenotype was confirmed (Supplementary
Figure 1). From this set, one clone for syringaldehyde
Figure 1 Functional metagenomic platform for discovery of novel functional
genetic elements from diverse environmental microbiomes. Shown is a
schematic detailing the key steps required for selecting functional genetic
elements from diverse environments that confer a desired selective advantage to
a microbial catalyst. Metagenomic DNA is directly extracted from arbitrary
environmental samples without earlier culturing steps, purified, and transformed
into a microbial host of interest. The entire library of putative functional genetic
elements is subjected to a selection pressure (e.g. chemicals at inhibitory
concentrations or recalcitrant substrates) that only allows survival of hosts
containing functional genetic elements, which counteract the selection pressure
(e.g. by allowing usage of the recalcitrant substrates or by conferring tolerance by
intracellular or extracellular inactivation or efflux of the inhibitory compound). This
scheme is ideally suited for discovery of novel functional genetic elements for
biomass conversion to biofuels.
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(mgSyrAld) and one clone for 2-furoic acid (mgFurAc), with
the greatest difference in cell growth when compared with
control at 1.55 g/l syringaldehyde and 0.8 g/l 2-furoic acid,
respectively, were selected for analysis of growth kinetics
(Materials and methods). Metagenomic inserts from these
clones were extracted and retransformed into wild-type E. coli
to confirm that the improved phenotype was due to the
presence of the metagenomic insert (Materials and methods).
The phenotypic improvements were 5.7-fold for syringalde-
hyde and 6.9-fold for 2-furoic acid, expressed as fold
improvements in cell growth at an inhibitor concentration
that results in a 90% reduction of wild-type E. coli cell growth
(Figure 2A and B).
The mgSyrAld and mgFurAc metagenomic inserts were
sequenced at three-fold coverage, assembled, and annotated
(Figure 2C and D) (Materials and methods; Supplementary
Tables II and III). Regions of the metagenomic sequences with
the highest detectable homology to the NCBI non-redundant
nucleotide database using BLAST (Altschul et al, 1990) are 7%
of mgFurAc with 79% identity to a region of the Pelobacter
propionicusDSM 2379 genome and 1% of mgSyrAld with 73%
identity to a region of the Burkholderia ambifaria AMMD
chromosome 2, indicating that the selected metagenomic
sequences are largely novel. Based solely on the sequence
and computational annotation of the inserts, it is difficult to
predict which genes are responsible for the improved tolerance
especially as the mechanism of toxicity is poorly characterized
for these compounds. Therefore, we performed a loss-of-
function study with mgSyrAld and mgFurAc using transposon
mutagenesis to identify the functional genetic elements
contributing to the selected phenotypes (Figure 2C and D)
(Materials and methods). The 192 transposon-inserted clones
per inhibitor created for sequencing of the mgSyrAld and
mgFurAc fosmids were individually subjected to kinetic
growth survival assays in the presence of 1.4 g/l syringalde-
hyde and 0.8 g/l 2-furoic acid, respectively.
For mgSyrAld, 3 of the 192 unique transposon insertions
resulted in a knockdown of the improved syringaldehyde
tolerance, all mapping to either the promoter or the N-terminal
coding region of a 348 amino acid gene product annotated
to be a UDP-glucose-4-epimerase (Figure 2D) (Materials and
methods). For mgFurAc, 7 of the 192 unique transposon
insertions resulted in a knockdown of the improved 2-furoic
acid tolerance, with three hits mapping to the coding region
of a 342 amino acid gene product annotated to be a RecA
protein, and four hits mapping to a 111 amino acid gene
product with predicted membrane-spanning domains but
of unknown function (Figure 2C) (Materials and methods;
Supplementary information). Interestingly, these two genes
are more than 10 kb apart in the mgFurAc metagenomic
fragment, and none of the annotated genes between these
locations appear to contribute to the selected phenotype based
on the transposon mutagenesis results. Although the mechan-
ism of inhibition in E. coli by syringaldehyde and 2-furoic acid
is unknown, the gene hits identified in our selection may
provide starting points for discovery of the underlying modes
of inhibition and rescue (Supplementary information).
To verify that the three genes implicated in the loss-of-
function studies were necessary and sufficient for the
syringaldehyde and 2-furoic acid tolerance phenotypes, we
PCR amplified each gene from the corresponding selected
metagenomic fosmid (mgUdpE from mgSyrAld, and mgRecA
and mgOrfX from mgFurAc), sub-cloned them into an
expression vector, transformed these into wild-type E. coli,
and repeated the tolerance assays (Materials and methods;
Supplementary information). In all three cases, the individual
genes exhibited improved tolerance to the inhibitors when
compared with wild-type E. coli (Figure 3). The improved
syringaldehyde tolerance because of the mgUdpE gene was
very similar to mgSyrAld (Figure 3B). In contrast, both
mgRecA and mgOrfX were individually unable to completely
recapitulate the level of mgFurAc tolerance (Figure 3A), which
might be expected if both genes are required for the full
observed phenotype of mgFurAc. To test this hypothesis, we
created a bicistronic construct (mgRecA_mgOrfX) by sub-
cloning the mgOrfX gene and its upstream ribosome-binding
site (RBS) between the mgRecA gene and the transcription
terminator site. The bicistronic mgRecA_mgOrfX construct
exhibited improved 2-furoic acid tolerance when compared
with both individual genes, and more closely resembled the
growth behavior of mgFurAc (Figure 3A). This shows the
utility of metagenomic selections using large-insert metage-
nomic libraries to identify multiple genetic elements, which
can together contribute to improved phenotypes despite not
being immediately co-localized in gene sequence. For instance,
a metagenomic library smaller than 10 kb would have been
unable to capture the improved phenotype derived from the
action of both genes.
One of the goals of synthetic biology is to improve microbial
phenotypes by integrating multiple functional genetic
elements from arbitrary genetic or engineered sources. To test
whether the selected genes that confer tolerance to E. coli
when exposed to the biomass inhibitors syringaldehyde and
2-furoic acid individually could also confer tolerance to a
mixture of these inhibitors, we created a tri-cistronic construct
(mgRecA_mgOrfX_mgUdpE) by sub-cloning the mgUdpE gene
Table I Soil metagenomic libraries from which inserts conferring tolerance in E. coli to seven lignocellulosic compounds were selected
Library
#
Source Library
size
(Mb)
Metagenomic inserts selected encoding resistance to lignocellulosic inhibitors
Hydroquinone 4-methylcatechol 4-hydroxy-
benzaldehyde
Syringaldehyde 2-furoic
acid
Furfural Ethanol
1 pH 4.5 bog soil (NH) 200 X X X X
2 pH 5.5 bog soil (NH) 2500 X X
3 Urban park soil (MA) 1000 X X X
4 Dairy farm soil (MA) 1000 X X X X X X
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and its upstream RBS just downstream of the bicistronic
mgRecA_mgOrfX construct. The tri-cistronic construct exhib-
ited improved growth phenotypes in the presence of mixtures
of syringaldehyde and 2-furoic acid (Figure 3C; Supplementary
Figure S4) showing that genes selected using this metage-
nomic selection platform against individual inhibitors can be
combined to create constructs that confer tolerance toward
inhibitor mixtures.
Strain optimization has previously been achieved through
adaptive evolution (Yomano et al, 1998; Herring et al, 2006;
Liu, 2006) where rare beneficial genomic mutations can be
selected without earlier knowledge about the mode of
inhibition. Adaptive evolution is ideally suited for optimiza-
tion of the genomic inventory of functions in a given strain, but
the timescale for evolving entirely new functions is generally
prohibitive, as they typically require a substantial number
of specific mutations. One of the strengths of metagenomic
functional selections for strain improvement is that its
success in discovering functional genetic elements is similarly
independent of earlier knowledge regarding the mode of
inhibition of selected chemicals, while sampling a large
reservoir of novel genes from the metagenome.
The genetic machinery that we can evolve, select, and
engineer into microbial biocatalysts for tolerating or degrading
biomass inhibitory chemicals can be considered mechanisti-
cally analogous to genetic machinery encoding microbial
antibiotic resistance. Both biomass-derived inhibitors and
most antibiotic chemicals are produced naturally in the
environment (Walsh, 2003), and microbial communities have
likely evolved similar biochemistries to tolerate and process
these xenobiotics. Mechanisms of antibiotic resistance include
(a) adaptive genomic mutation that obscure the cellular target
of the drug without compromising the native cellular function,
(b) acquired mechanisms to degrade or expel the drug, often
gained through horizontal transfer through plasmid exchange,
and (c) adjusting expression in other pathways to increase
target production or bypass it with redundant functions
(Davies, 1994; Walsh, 2003). Metagenomic functional selec-
tions for biomass tolerance and conversion are likely to
uncover genetic machinery that parallels the second and third
mechanisms. Indeed, we hypothesize that the metagenomi-
cally selected proteins homologous to RecA and UDP-glucose-
4-epimerase encoding resistance to 2-furoic acid and syringal-
dehyde, respectively, may function to complement or rescue
the activity of their putatively compromised native cellular
counterparts (Supplementary information). In future applica-
tions of this methodology, mechanisms to enzymatically
metabolize biomass inhibitors may have enhanced utility
because they would increase the nutrient yield and net carbon
flux, though these mechanisms would be undesirable when
the intended tolerance phenotype is against the biofuel
product (e.g. ethanol).
The screening of metagenomic clone libraries from diverse
environmental sources has previously yielded numerous
biomolecules including novel proteases, amylases, cellulases,
and antibiotics (Brady and Clardy, 2000; Rondon et al, 2000;
Daniel, 2005; Warnecke et al, 2007), and the yields of these
methods appear primarily limited by the number of clones
that can feasibly be screened (Daniel, 2005). In compa-
rison, a library-wide selection scheme allows for exhaustive
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Figure 2 Sequence annotation and functional analysis of selected genetic elements improving biomass inhibitor tolerance in E. coli. (A, B) Improvements in inhibitor
tolerance toward 2-furoic acid and syringaldehyde because of metagenomic inserts. Inhibitor concentrations resulting in 90% reductions in growth yield were determined
for wild-type E. coli as 1.05 g/l for 2-furoic acid and 1.33 g/l for syringaldehyde. Improvements in E. coli growth yield at these concentrations because of metagenomic
inserts were 6.9-fold for 2-furoic acid and 5.7-fold for syringaldehyde, showed here as the mean (and standard deviation) of triplicate readings after 24 h of growth.
(C, D) The metagenomic inserts conferring tolerance to 2-furoic acid (mgFurAc) and syringaldehyde (mgSyrAld) were sequenced at 3 coverage and annotated
(Supplementary Tables II and III). Annotated genes for (C) mgFurAc and (D) mgSyrAld are shown as filled arrows, with the orientation denoting the relative direction of
transcription based on an arbitrary sense strand. Transposon mutagenesis, followed by reselection of the tolerance phenotypes, was used to identify functional genetic
elements in mgFurAc and mgSyrAld that contribute to the selected phenotypes (genes colored red and labeled) (Supplementary information). Vertical bars along the
bottom of each sequence–position axis denote positions of transposon insertion in the loss-of-function study (black denotes no effect, red denotes loss-of-function).
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interrogation of the enzymatic reservoir encoded within meta-
genomic libraries that can be made using current techniques
(p51010 bp) (Riesenfeld et al, 2004; Daniel, 2005). Functional
selections have been designed for hundreds of anabolic,
catabolic, and resistance phenotypes in E. coli (Neidhardt
et al, 1996; Sommer et al, 2009), and opportunities exist for
the design of selections for other biotechnologically relevant
phenotypes including controlled flocculation, surface adhesion,
natural competency, and cell–cell communication (Williamson
et al, 2005).
We have shown that metagenomic functional selections can
successfully discover functional genetic elements encoding
chemical tolerance relevant to biomass conversion. The same
platform can be applied to select for microbial usage and
production of specific biomass chemicals. The repertoire of
biomass substrates that can be used by a microbial biocatalyst
has been expanded by transfer of specific genetic machinery
for substrate metabolism from other microbes with these
properties (Jin et al, 2005). Similarly, substrate usage
machinery may be selected from a metagenomic clone library
by providing the substrate as the sole source of a required
nutrient (e.g. carbon, nitrogen), only allowing clones expres-
sing functional genes enabling substrate usage to grow
selectively. Functional selections for chemical production
can be achieved in a biocatalyst metagenomic clone library
that contains a biochemical circuit that links the presence of
the desired product to a selectable resistance or usage
phenotype. For instance, a circuit can be designed where a
transcription factor responsive to the stoichiometric presence
or absence of the product controls the expression of an
antibiotic resistance gene (Desai and Gallivan, 2004).
A distinguishing feature of synthetic biology is the emphasis
on integrating arbitrary genetic elements to generate robust
and predictable biocatalysts to solve multiple biological,
chemical, and engineering problems including fuel generation,
environmental remediation, and pharmaceutical production
(Baker et al, 2006). Our work shows that metagenomic
functional selections enable the direct discovery of novel
genetic elements from Nature’s enzymatic catalogue, provid-
ing a route for expanding the synthetic biology tool box.
Materials and methods
Environmental metagenomic DNA library
construction
Soil samples (200–500 g) were collected from urban parks (MA), farm
land (MA), and bogs (NH). Metagenomic DNAwas extracted from 10 g
of soil using the PowerMax Soil DNA Isolation kit (Mobio Laboratories
Inc.), using a modified protocol (Supplementary information). High
molecular weight (40–50 kb) DNAwas size selected and purified using
a pulse-field gel apparatus (Supplementary information). Size-selected
gel-purified DNA was blunt-end repaired using the End-It DNA End-
Repair kit (Epicentre Biotechnologies), purified by two serial phenol/
chloroform extractions, and concentrated by ethanol precipitation
(Supplementary information). Libraries of purified end-repaired
40–50kb metagenomic DNA in E. coli were created using the
CopyControl Fosmid Library Production kit (Epicentre Biotechnolo-
gies). For each library, B250ng of DNA was ligated to 0.5mg of the
linearized fosmid pCC1FOS vector, packaged using replication-
deficient phage extract, infected into E. coli strain EPI-300, and library
size determined by dilution titering on LB agar plates containing
12.5 mg/ml chloramphenicol. E. coli-infected metagenomic DNA
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Figure 3 Inhibitor tolerance phenotypes encoded by sub-cloned metagenomic
genes for (A) 0.8 g/l 2-furoic acid, (B) 1.4 g/l syringaldehyde, and (C) mixtures of
2-furoic acid and syringaldehyde; 24 h kinetic growth curves are shown for E.coli
clones harboring different combinations of sub-cloned metagenomic tolerance
genes. Error bars represent standard deviation from triplicate kinetic readings.
(A) For 2-furoic acid, the constructs containing the individual genes mgOrfX and
mgRecA recapitulate only part of the tolerance phenotype; however, a bicistronic
construct (mgRecA_mgOrfX) fully recapitulates the phenotype of the full-length
selected fosmid (mgFurAc), showing that the two genes are necessary and
sufficient for conferring the 2-furoic acid tolerance phenotype. (B) For
syringaldehyde, the sub-cloned metagenomic UDP glucose-4-epimerase gene
(mgUdpE) fully recapitulates the phenotype of the full-length selected fosmid
(mgSyrAld). (C) A tri-cistronic construct (mgRecA_mgOrfX_mgUdpE) enables
improved tolerance to mixtures of 2-furoic acid and syringaldehyde showing that
the identified tolerance genes can be combined to generate multifunctional
constructs.
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libraries were grown to mid-log phase in 10ml LB–12.5mg/ml
chloramphenicol, and frozen down at 801C in 1ml aliquots in 15%
glycerol. Each frozen stock was subsequently confirmed to have
B1–5108 colony forming units perml.On the basis of the determined
library sizes, each library aliquot saved contained over 100 cell copies
per individual 40–50 kb metagenomic DNA fosmid library clone.
Selection of functional genetic elements
from metagenomic libraries
Growth selections were performed onmetagenomic libraries from four
different soils coveringB4.7Gb of genetic material at the determined
inhibitory concentrations of seven biomass inhibitors (Table I;
Supplementary Table I; Supplementary information). On the basis of
the determined library sizes and titers of the frozen library stocks,
inocula were prepared to yieldB100 cell copies of each metagenomic
DNA library clone per selection (e.g. 2106 cells were plated out from
a library originally assayed to contain 2104 clones). Cells were
spread on LB agar plates containing 12.5mg/ml chloramphenicol and
the inhibitor at the selective concentration (Supplementary Table I).
Growth of colonies was assayed after 48 h of growth at 371C.
In all, 40 metagenomic DNA library clones, each conferring
tolerance to syringaldehyde or 2-furoic acid, were chosen for further
analysis of encoded functional parts from the selected inhibitor plates.
For 2-furoic acid, six to seven tolerant clones each were chosen from
selected libraries 1, 2, and 3 (Table I). For syringaldehyde, 10 tolerant
clones each were chosen from selected libraries 3 and 4 (Table I). Each
colony was grown to saturation (16–18 h) at 371C with shaking in
liquid LB medium containing 12.5 mg/ml chloramphenicol (hereon
referred to as LB-chlor). Saturated cultures were diluted 1:40 in fresh
LB-chlor and grown to mid-log phase (1–2 h) at 371C with shaking.
Log-phase cultures were inoculated (1:40) into LB-chlor containing
one of three concentrations of the relevant inhibitor (2-furoic acid: 0.8,
7.9, and 15 g/l; syringaldehyde: 1.55, 1.775, and 2 g/l), with
concentrations chosen to sparsely span the range of previously
reported inhibitory concentrations of these compounds (Zaldivar
and Ingram, 1999; Zaldivar et al, 1999). Cell growth after 24 h at 371C
with shaking was determined by end-point turbidity measurements
at 600nm using a Versamax microplate reader (Molecular Devices)
(Supplementary Figure 1).
One metagenomic clone each, with the greatest difference in cell
growth when compared with control for syringaldehyde (mgSyrAld)
and 2-furoic acid (mgFurAc) (Supplementary Figure I) was chosen for
further analysis. To confirm that the observed tolerance in the selected
clones was a result of the selected metagenomic DNA, fosmids from
the metagenomic clones were extracted using the FosmidMAX DNA
Purification kit (Epicentre Biotechnologies). Purified fosmids were
then retransformed into an electrocompetent version of the same
control E. coli strain using a standard electroporation protocol. The
retransformed clones recapitulated the improved inhibitor tolerance
compared with the E. coli control. Growth kinetics for these clones
were measured at 11 concentrations per inhibitor, evenly spanning the
concentration ranges 0–1.5 g/l for 2-furoic acid and 0–3 g/l for
syringaldehyde. Kinetic measurements were carried out in triplicate
for each metagenomic clone and E. coli control by turbidity
measurements at 600 nm every 5min over 24 h at 371C with shaking
in a Versamax microplate reader. Inhibitor concentrations resulting in
90% reductions in cell growth after 24 h of growth at 371C were
determined for the control E. coli as 1.05 g/l for 2-furoic acid and
1.33 g/l for syringaldehyde (Supplementary Figure 2).
Sequencing of metagenomic inserts
The metagenomic inserts from mgFurAc and mgSyrAld were chosen
for DNA sequencing and analysis. Sequencing clone libraries were
created by in vitro insertion of a transposon carrying unique
sequencing primer sites and a kanamycin resistance cassette into
random positions in the purified metagenomic DNA fosmids, followed
by transformation into the control E. coli strain, using the EZ-Tn5
oKAN-24 Insertion kit (Epicentre Biotechnologies). In all, 192 single
transposon-inserted clones per fosmidwere sequenced bi-directionally
to yield approximately three-fold sequence coverage of theB40kb inserts.
Sequences were assembled into contigs using Phred/Phrap (University
ofWashington; http://www.phrap.org/phredphrapconsed.html). Each
assembly yielded 2–5 contigs. Primers were designed to close gaps
between contigs and sequences resulting from this additional round of
primer walking yielded sufficient sequence information for complete
assembly of single full-length contigs for both metagenomic DNA
inserts. The Rapid Annotation using Subsystem Technology Server
version 2.0 (Aziz et al, 2008) was used to annotate both full-length
contigs, and annotation information for mgFurAc and mgSyrAld are
tabulated in Supplementary Tables II and III, respectively.
Loss-of-function study by transposon
mutagenesis
To identify the genes within the B40 kb metagenomic DNA inserts
responsible for the improved tolerance, we performed a loss-of-
function study on mgFurAc and mgSyrAld. The 192 transposon-
inserted clones created for sequencing of the mgFurAc and mgSyrAld
fosmids were individually subjected to growth survival assays in the
presence of 0.8 g/l 2-furoic acid and 1.4 g/l syringaldehyde, respec-
tively. Kinetic measurements were carried out for each transposon-
inserted clone, along with triplicate measurements for the original
metagenomic clone and E. coli control at these concentrations, by
600nm turbidity measurements every 5min over 24 h at 371C with
shaking in a Versamax microplate reader. Three separate transposition
events in mgSyrAld and seven separate transposition events in
mgFurAc resulted in knock down of the relevant tolerance phenotypes.
The inhibitor tolerance growth kinetics of these transposon-inserted
clones was retested in triplicate to confirm the knockdown phenotype.
The exact sequence position for each transposition event was mapped
by sequence comparison of the unique 19 bp Mosaic-End sequence
from the EZ-Tn5oKAN-24 Transposon found in each raw sequence
read to the fully assembled and annotated mgFurAc and mgSyrAld
contigs, using BLAST (Altschul et al, 1990).
Sub-cloning metagenomic genes implicated
in tolerance phenotypes
The three genes (mgUdpE, mgRecA, mgOrfX) implicated in the
syringaldehyde and 2-furoic acid phenotypes were PCR amplified
from themgSyrAld andmgFurAc fosmids using primers designed to be
homologous to at least 18 bp to the 50 or 30 regions of the annotated
genes, and adding KpnI and HindIII restriction sites to the 50 or 30
regions, respectively (Supplementary information). These amplicons
were digested with KpnI and HindIII (New England Biolabs), ligated
into the KpnI and HindIII sites of the multiple cloning site (MCS) of the
pZE21-MCS1 vector (Lutz and Bujard, 1997), and transformed into
electrocompetent EPI-300 E. coli using a standard electroporation
protocol. The bi-cistronic mgRecA_mgOrfX construct was created by
cloning the RBS of pZE21-MCS1 and the mgOrfX gene into the EcoRV
and MluI sites of the pZE21-MCS1 construct containing mgRecA
(Supplementary information). An additional region containing an
XbaI site (which is unique to all three genes and the original pZE21-
MCS1 vector) was added to the 30 end of the mgOrfX gene in this
construct. The tri-cistronic mgRecA_mgOrfX_mgUdpE construct was
created by sub-cloning the RBS of pZE21-MCS1 and the mgUdpE gene
into the new XbaI site and the MluI site of the pZE21-MCS1 construct
containing the bicistronic mgRecA_mgOrfX (Supplementary informa-
tion). Inhibitor tolerance growth kinetic assays were performed as
before, with LB medium supplemented with 12.5 mg/ml chloramphe-
nicol for constructs in the fosmid vector (large-insert metagenomic
clones and control) or 50 mg/ml kanamycin for constructs in the pZE21
vector (sub-cloned genes and control). The individual 2-furoic acid
and syringaldehyde assays were performed at a concentration of 0.8
and 1.4 g/l, respectively. The fosmid control (Supplementary Meth-
ods) used as a control to select the original metagenomic clones was
again used as a control in these recapitulation assays. The mixed
inhibitor assays were performed along an even nine-step gradient
formulated between a maximum concentration mixture of 0.80 g/l
2-furoic acid and 1.55 g/l syringaldehyde and a minimum concentra-
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tion mixture of media lacking inhibitors. E. coli EPI-300 harboring the
pZE21-MCS1 vector without an insert was used as a control for the
mixed inhibitor assays.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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